Quantitative Analysis of Target Coverage and Germinal Center Response by a CXCL13 Neutralizing Antibody in a T-Dependent Mouse Immunization Model

Author： Brodfuehrer Joanne   Rankin Andrew   Edmonds Jason   Keegan Sean   Andreyeva Tatyana   Lawrence-Henderson Rosemary   Ozer Josef   Gao Huilan   Bloom Laird   Boisvert Angela   Lam Khetemenee   Lee Julie   LaBranche Timothy   Syed Jameel   Miao Wenyan   Singh Pratap  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.31, Iss.3, 2014-03, pp. : 635-648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates

By  

Current Gene Therapy, Vol. 14, Iss. 3, 2014-06 ,pp. : 200-210

Bentham Science Publishers

Access to resources Recommend Favorite

CXCL3 is a Potential Target for Breast Cancer Metastasis

By  

Current Cancer Drug Targets, Vol. 14, Iss. 3, 2014-03 ,pp. : 294-309

Bentham Science Publishers

Access to resources Recommend Favorite

Impression of Clinical Worsening Fails to Predict Interferon-β Neutralizing Antibody Status

By Rot U   Sominanda A   Fogdell-Hahn A   Hillert J  

The Journal of International Medical Research, Vol. 36, Iss. 6, 2008-11 ,pp. : 1418-1425

Field House Publishing

Access to resources Recommend Favorite

The Chemokine CXCL10 as a Therapeutic Target in Animal Models of Neuroinflammatory Disease

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 10, 2006-12 ,pp. : 683-688

Bentham Science Publishers

Access to resources Recommend Favorite

CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders

By  

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 111-121

Bentham Science Publishers

Access to resources Recommend Favorite